In the Editorial launching the very first issue of The Journal of Investigative Dermatology, Dr. Marion Sulzberger wrote, ''y the laboratory investigation of today is the practice of tomorrow '' [1]. This 50th Anniversary Issue is filled with evidence of the maturation of investigative dermatology, but what has been the impact of such basic research in cutaneous biology on the practice of dermatology? The purpose of this treatise is twofold: (1) To examine the state of research in cutaneous biology in 1988 by presenting how the modern tools of molecular and cellular biology are being applied to the study of the skin, and (2) to demonstrate how this scientific foundation has provided the basis for modern therapeutics. In 1988, the investigators involved in research in cutaneous biology brought a wide range of training and different experimental approaches to their areas of investigation: the molecular biologist analyzing the subcellular details of keratinocyte differentiation, of collagen synthesis, or of the synthesis and secretion of the extracellular matrix; the cell biologist studying signal transduction or membrane function; the cellular immunologist dissecting the complex interactions of the immune response in the skin; the experimental pathologist studying wound healing; the photobiologist evaluating the subcellular, cellular and systemic effects of ultraviolet light; the biochemist studying melanization or the barrier function of lipids of the stratum corneum; the radiation biologist characterizing DNA repair mechanisms; the pharmacologist measuring percutaneous absorption; the physiologist considering the physical properties of the skin; the cell biologist or pharmacologist studying the mechanism of action of drugs. The historical term ''investigative dermatology'' has surely evolved to include all aspects of cutaneous biology. The modern scientist studying the biology of the skin may be in a Department of Dermatology or other clinical departments such as Surgery, Medicine or Pediatrics, or in such basic science departments of Molecular, Cellular and Developmental Biology, Anatomy, Pathology, Microbiology/Immunology, or Pharmacology. Although this broad spectrum of investigation is published in many journals, The Journal of Investigative Dermatology is the one place where work on all aspects of cutaneous biology is welcomed. It is the major journal which encompasses the complete spectrum of research in cutaneous biology. This treatise will present a selected summary of the state of research in cutaneous biology in the 50th Anniversary year of the founding of the SID and JID, and also a perspective on the influence of research in cutaneous biology on the practice of dermatology. The first section will demonstrate how the tools of molecular and cellular biology are being applied in 1988 to study the complex structure and function of the skin. Representative papers from the JID and other journals during the 50th Anniversary year will be used as examples. The second section will demonstrate how this basic knowledge has influenced treatment of disease.
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THE CURRENT STATE OF RESEARCH IN CUTANEOUS BIOLOGY
Sophisticated techniques of laboratory research have permitted investigators to study in detail the molecules which are the building blocks of cells, and to learn how these molecules control cellular functions. The tools of molecular biology can be used to better understand the molecular details of gene activation and transcription and of protein synthesis, and have led to cloning and sequencing of the genes and to determination of structure of certain proteins. This research has provided probes to facilitate analysis of protein glycosylation, packaging and secretion, and to study hormones, receptors, growth factors, cytokines, matrix proteins, cytoskeletal and membrane components. Understanding interactions at the molecular and cellular levels leads to better understanding of complex cellular interactions. The complicated interaction of cytokines, growth factors, adhesion molecules, and recognition structures in the immune system is an excellent example of complex cellular interactions. Such complexity also is found in the chemistry of nerve conduction, in the interactions of the dermis and epidermis producing the basement membrane zone, in the biology of the adnexal structures of the skin, and in the interactions of endothelial cells, mast cells, and fibroblasts in controlling cutaneous microcirculation. Finally, the sum of such complex interactions comprises the biology of each organ system, and the equally complex interactions among organ systems define the biology of the whole organism. The tools of molecular biology enhance research tremendously at all levels of complexity in this hierarchy, from the molecular to organ system level (Fig 1) .
and the enzyme reverse transcriptase, which produces DNA (complementary DNA or cDNA) from RNA sequences and facilitates the sequencing of genes coding for particular proteins. The sequencing of genes and determination of protein primary, secondary and tertiary structure are important investigative goals, but this research may also provide clues to the control of gene expression.
Molecular Probes to Study Complex Biology. Molecular biology
techniques can also expand our understanding of how particular genes, through their protein products, affect cell function, complex cellular interactions, and the pathophysiology of disease. Molecular biology provides a variety of highly specific and useful probes for studying genes, message and protein structure and distribution as summarized in Table I . These tools are being applied with impressive effectiveness in dissecting the complexities of cutaneous biology from the molecular to the organ level. A subsequent section of this paper will summarize how these tools have been applied in 1988 to study several important groups of proteins central to cutaneous biology: growth factors, extracellular matrix proteins, immunologic cytokines, and antigens recognized in autoimmune skin diseases, adhesion molecules, and keratins.
Restriction Fragment Length Polymorphisms. A very important tool in molecular genetics is the analysis of restriction fragment length polymorphisms (RFLP) to determine genetic alleles which are closely linked with particular diseases. Restriction enzymes are used to cut DNA at specific sites determined by nucleotide sequence. The resulting fragments are then separated on a gel by molecular weight and are probed for the gene of interest. As shown in Figure 2 , DNA sequences with different restriction sites produce fragments of different length. The different patterns from different individuals represent polymorphisms in nucleotide sequence. These polymorphisms can be compared in different diseases and control groups and then analyzed to determine if the gene in question contains alleles which are highly associated with particular diseases. In 1988, analysis of RFLPs has produced important information on the genetic control of two dermatologic diseases, pemphigus vulgaris and psoriasis vulgaris. Two recent papers report the detection of diseasespecific RFLPs in one genetic subset of pemphigus vulgaris, a finding tantamount to identifying an allele of the HLA Dq-beta gene which determines the occurrence of disease [2, 3] . The allele in question was invariably present in all pemphigus patients and was present in few of the controls. In the past, close linkage of pemphigus vulgaris with particular HLA alleles has been viewed as evidence of the genetic determination of the immunologic reactivity that leads to the disease. This new work identifies one allele in the HLA D region which may determine disease.
Psoriasis is a heterogeneous disease of complex pathophysiology. Ozawa and his coworkers [4] analyzed RFLPs of genomic DNA of the HLA-C gene in HLA-Cw6 and Cw7-positive psoriatic patients and controls. No polymorphisms were seen in the psoriatic patients, and two fragments uniformly found in psoriatics were lacking in some controls. Although this work does not identify the gene responsible for psoriasis, it indicates that certain invariant alleles in the HLA-C locus may be necessary for the development of disease in one subset of psoriasis. Thus, 2. cDNA probes to identify specific cellular mRNA by hybridization in situ.
3. Specific RNA probes to identify specific genes in cell nuclei by hybridization in situ.
4. Short nucleotide probes to identify particular segments in genes in nuclei or on Southern blots.
5. Short nucleotide primers to amplify particular genes by the polymerase chain reaction (PCR).
6. Production of large amounts of recombinant molecules, facilitating more detailed study of protein function.
7. Use of recombinant molecules to produce highly specific monoclonal antibody probes to different protein epitopes. 180S NORRIS, HUFF, AND WESTON in two major skin diseases suspected to be genetically determined, there are now techniques which can identify the genes which determine disease.
Study of Gene Rearrangement. An important discovery in molecular genetics was that certain specialized cells randomly rearrange their genes during certain stages of differentiation or activation [5, 6] . This is an important means of generating diversity in gene products. Such gene rearrangement in the course of B lymphocyte and T lymphocyte activation leads to the vast repertory of different antibody and T cell receptor specificities. Study of this phenomenon has led to basic and critical information regarding the control of the specificity of the immune response.
Such gene rearrangements have also been studied as markers of clonality to better understand the biology of B and T cell lymphomas [7] . In investigative dermatology, the study of T cell receptor gene rearrangements in cutaneous T cell lymphoma (CTCL) has been effectively used to understand the origin of clonal disease in this indolent lymphoma [8] . In a current JID paper, Berger and coworkers [9] extend previous observations on clonality in CTCL by demonstrating dual genotypes in a number of CTCL patients. In addition to clonal rearrangement of the beta chain gene of the T cell receptor in 13 patients, immunoglobulin gene rearrangements were found in four patients. The precise meaning of gene rearrangements in T cell lymphomas is not totally clear due to the apparent demonstration of clonality in the benign disease lymphomatoid papulosis [10] . These types of study should allow us to better understand patterns of T cell activation and the mechanisms of malignant transformation.
Understanding Mechanisms for Control of Gene Transcription and Translation. Understanding how the promotion of particular genes occurs, how exons are regulated, and how transacting factors control gene expression are important questions in molecular biology. Two papers in the JID illustrate how such questions are being addressed in the study of keratin and elastin synthesis. The coordinate synthesis of keratins at different stages of differentiation is an important aspect of epidermal differentiation. Lessin et al. [11] studied the control of synthesis of Keratin 1 (Type II 67 kDa) and Keratin 10 (Type I 57 kDa) which are co-expressed in terminally differentiated epidermal cells. They mapped these two genes to chromosomes 12 and 17, respectively. Since they are not linked on the chromosome, but are co-expressed during differentiation, it is reasonable to postulate that transacting factors regulate their transcription and translation.
How is diversity in elastin molecules determined? To study this question, Fazio et al. [12] constructed a cDNA library from fibroblast mRNA and screened by plaque hybridization with elastin cDNAs. They found in the recombinant plaques identified that there was considerable variability in the primary nucleotide sequence of the elastin cDNAs. The authors felt that alternative splicing of exons from the primary elastin transcripts produced the variability, and proposed that this might be an important means of producing elastin with variable biologic properties.
Localization of the Site of Protein Synthesis by In Situ Hybridization. As detailed earlier, molecular probes may complement previous studies of protein localization tissue by demonstrating the genes or RNA message coding for proteins and by indicating which cells encode for a protein. Again, two recent JID papers demonstrate the power of in situ hybridization techniques. The production of fibronectin by basal cell epitheliomas (BCE) and its presence around tumor islands has been demonstrated in numerous elegant lmmunohistology studies. Peltonen et al. [13] recently confirmed that the tumor cells in a BCE contain mRNA for fibronectin and secrete the protein product. Figure 3 shows fibronectin-specific mRNAs in the peripheral pallisading basal cells in a BCE.
The production of fibrosis in scleroderma is a complex process in which immunologic factors, mast cells, and growth factors all appear to contribute. Using cDNA probes for pro 1(1) and pro 1 (III) collagen, Kahari et al. [14] showed increased levels of messenger RNA for procollagen in fibroblasts associated with inflammatory cells in the dermis of scleroderma lesions. As shown in Figure 4 , the procollagen message appears associated with blood vessels and inflammatory cells. This evidence strongly implicates the interaction of inflammatory cells (and perhaps mast cells) and endothelial celis in the local activation of collagen synthesis by transcription of procollagen message.
Examples of Application of Advances in Molecular and Cellular Biology to the Understanding of Cutaneous Biology and Disease
Although it is impossible to consider here all areas of research in cutaneous biology in which modern molecular biology has produced significant advances, we will discuss progress relating to six major groups of crucial proteins which are centrally involved in many cutaneous diseases: growth factors, extracellular matrix proteins, immunologic cytokines, antigens recognized in autoimmune diseases, adhesion molecules, and intermediate filaments. Understanding of the roles of these proteins has been greatly expanded by recent advances in molecular biology.
Growth Factors. The major growth factors with implications for cutaneous biology are listed in Table II . For most of these factors, the genes have been sequenced, protein sequences and structures have been determined, and recombinant molecules have been developed. In addition, cellular receptors for the factors have been identified and are being characterized. With the elegant probes for growth factors and for their receptors that have been developed, extensive studies of the function and relevance of these factors to skin biology and disease are underway. It is impressive to realize that all of this effort has evolved from the simple observations by Stanley Cohen and his colleagues, featured as a ''Citation Classic'' in another section of this issue (pages).
There are many current papers describing important functions of growth factors in the skin. Two examples are papers by O'Keefe et al. [15] , demonstrating the stimulation of the growth of keratinocytes in vitro by basic fibroblast growth factor (bFGF), and Halaban et al. [16] , showing similar growth stimulation of melanocytes by bFGF. Perhaps bFGF is an important autocrine factor controlling keratinocyte proliferation and differentiation, and modulating melanocyte proliferation and response to biological stimuli such as ultraviolet light (UVL) and vitamin D.
A particularly important contemporary paper is the report by Ellis et al. [17] studying the implication of growth factors in paraneoplastic syndromes. These Vanderbilt University investigators described a patient with melanoma who also had acanthosis nigricans, extensive seborrheic keratoses, and acrochordons. Based on the knowledge that epidermal growth factor (EGF) receptors bind both EGF and transforming growth factor alpha (alpha-TGF), and that this ligand-receptor interaction appears to be important in controlling the growth of epidermal keratinocytes, they studied the expression of EGF receptors, the binding of EGF and alpha TGF in tissue, and the excretion of growth factors in the urine. This patient exhibited elevated EGF receptors in the skin and elevated alpha-TGF in the urine. After removal of the tumor, the acanthosis nigricans, seborrheic keratoses and acrochordons regressed, the tissue EGF receptors decreased, and the urine alpha-TGF decreased. The implication of this study is that growth factors may control the epidermal hyperproliferation in certain cutaneous signs associated with cancer. This study highlights the potentially important clinical roles of such growth factors.
Extracellular Matrix Proteins. The maturation of research on the extracellular matrix and its role in cutaneous biology is elegantly summarized in this volume by Uitto, Olsen and Fazio. The cell biology of newer collagens and matrix proteins is also detailed in recent reviews in the Annual Review of Cell Biology [18, 19] . As indicated in Table III , a growing number of collagens, elastins, proteoglycans, and matrix proteins have been found to be involved in basement membrane assembly, dermal structure, and the interactions between dermis, epidermis and epithelial cells.
In recent years, much emphasis has been placed on the role of epidermal keratinocytes in the synthesis of basement membrane zone components. Two 1988 JID papers illustrate that dermal fibroblasts may also be involved in basement membrane formation. Woodley et al. established that fibroblasts synthesize laminin [20] , a crucial basement membrane component also produced by keratinocytes. In a very interesting study, Delvoye et al.
[21] explored the role of fibroblasts on basement membrane synthesis by using a complex composite culture system. These investigators showed that the pattern of laminin, Type IV collagen, and heparan sulfate proteoglycan produced by cultured keratinocytes could be influenced by co-culture with fibroblasts, and thereby established that fibroblasts influence the pattern of synthesis or deposition of ECM components by keratinocytes.
New relationships of keratinocytes and the ECM are also being appreciated. Enenstein and Furcht [22] reported that the neuronal adhesion molecule epinectin could be synthesized by epidermal keratinocytes and probably attaches to heparan sulfate proteoglycan, thus establishing another potential adhesion mechanism between the epidermis and the ECM. Another adhesion factor is thrombo-spondin, which was shown by Varani and Nickoloff to be synthesized by cultured human keratinocytes under conditions producing a basal cell phenotype. Culture conditions which favored differentiation terminated thrombospondin synthesis [23] . Although gamma interferon decreased thrombospondin synthesis, the transforming growth factors did not [24] .
New relationships between ECM synthesis, growth factors, and keratinocyte spreading are also being discovered. Transforming growth factor beta (TGF-B) has been shown to be important in keratinocyte spreading, and in secretion of proteins and enzymes involved in wound healing. Hebda [25] described enhanced outgrowth of epidermal explant cultures by TGF-B [ Fig 5] . Mansbridge et al. showed that TGF-B enhances the ''regenerative maturation'' of cultured keratinocytes, as indicated by the patterns of proteins detected in gel electrophoresis [26] . Wikner et al showed that TGF-B stimulates fibronectin synthesis and secretion by cultured human keratinocytes ( Fig 6) ; plasminogen activator synthesis was also increased [27] . As previously reported, fibronectin [28] and urokinase-and tissue-type plasminogen activator [29] are found in the migrating epidermal tongue during wound healing in vivo. These studies are relevant not only to the healing surgical wound, but also to repair of epidermal and dermal injuries in inflammatory skin diseases, and to development and repair in mechanobullous disorders.
Immunohgic Cytokines. For years, the complex cellular interactions of the immune response have been poorly characterized. In many ways, these interactions were ''phenomenological''; even the many lymphokines which modulate functions of different cells involved in inflammation were named by their function and not by their structure. Molecular approaches to understanding the lymphokines have led to identification of a basic core of important cytokines, listed in Table IV . Numerous Interleukin 1 establishes the level of T cell responsiveness in any organ and also has multiple systemic effects; Interleukin 2 activates primed T lymphocytes and is required for T and B lymphocyte activation; and gamma interferon has many important effects in amplifying the effector arms of the immune response (for reviews, see [30, 31] ). The availability of pure recombinant molecules and specific neutralizing antibodies will facilitate investigation of the exact functional role of immunologic cytokines.
The first immunologic cytokine found to be associated with the epidermis was Epidermal Cell-Derived Thymocyte Activating Factor (ETAF) [32, 33] , which has recently been shown to be largely IL-1, plus IL-3 and IL-6 [30] . There was much active investigation in 1988 on control of the secretion of IL-1 by different epidermal cells, and the production of IL-1 inhibitors, especially contra IL-1, which is induced by UV radiation [34] . An important development was the identification of GM-CSF (a major colony stimulating factor for macrophages and granulocytes) as a product of epidermal keratinocytes [35] . Not only is this cytokine important in stimulating the proliferation of granulocytes and macrophages (and possibly also Langerhans cells), but it is also an important activator of granulocytes. As reported by Kapp and colleagues [36] , GM-CSF activates neutrophil oxidative metabolism. GM-CSF released by epidermis is likely to be an important mediator of neutrophil activation in the skin (Fig 7) .
Our perception of the epidermis as an immunologic organ has changed greatly over the past ten years. Perspectives on the importance of Langerhans cells and Dendritic Epidermal T cells are provided elsewhere in this issue, in the contribution by Krueger and Stingl (pp 32S-52S) and in the Citation Classic by Soter (pp 161S-163S). The production of cytokines, colony stimulating factors and growth factors by epidermal keratinocytes also are crucial in the immunologic functions of skin (for review of epidermal immunology, see [30] ). As summarized in Figure 8 , the epidermis secretes cytokines which modulate T and B cell activation and which regulate monocyte/macrophage as well as granulocyte function. The epidermis also produces growth factors which profoundly affect the function of fibroblasts, endothelial cells, and keratinocytes and melanocytes, in addition to inflammatory cells. There is still much to be learned about the complex interaction of cytokines and growth factors in control of cutaneous immunologic responses, and such insights are crucial to understanding the inflammatory dermatoses.
Antigens Involved in Autoimmune Diseases. Research in the pathomechanisms of the bullous diseases has greatly enhanced our understanding of the mechanisms of the variants of pemphigus, bullous pemphigoid, dermatitis herpetiformis, herpes gestationis, and linear IgA dermatosis. In most instances, distinctive autoantibodies and their tissue localizations have been identified. This knowledge has revolutionized the diagnosis of the immunologic bullous diseases and has provided a solid basis for considering and developing new treatments.
Another important aspect of this research is the use of antibody probes from patients' sera to characterize antigens which are biologically important components of the epidermis, basement membrane zone and dermis. Several important papers in this area can be found in the 1988 literature. In a landmark paper, Eyre and Stanley report that pemphigus vulgaris (PV) and pemphigus foliaceus (PF) can be absolutely distinguished on a molecular level [37] . Pemphigus vulgaris sera immunoprecipitate a complex of polypeptides of 210,130 and 85 kDa, while pemphigus foliaceus sera immunoprecipitate a complex of 260,160,110 and 85 kD. The 85 kD protein is common to both complexes. The authors speculate that these complexes are involved in keratinocyte adhesion.
Epidermolysis bullosa acquisita (EBA) patients' sera contains an autoantibody which reacts with 145 and 290 kDa proteins in skin. Two papers from Woodley and his colleagues in 1988 further characterize this antigen [38, 39] . The 145 protein appears to arise from the 290 kDa protein by collagenase digestion. EBA sera recognize the carboxyterminus of type VII procollagen extracts in skin, as well as purified type VII procollagen. The collagenous domain of the EBA antigen is located in the sub-lamina densa region, and is likely to be a part of the type VII collagen found in the anchoring filaments.
Stanley and colleagues [40] have also apparently identified the major bullous pemphigoid antigen as a 230 kD polypeptide which is best identified by immunoprecipitation of extracts of cultured human 184S NORRIS, HUFF, AND WESTON keratinocytes, and less well by immunoblotting of extracts of human epidermis. Other immunoreactive bands can be identified using BP patients' sera, but the authors believe that this is the major BP antigen. Herpes gestationis (HG) is an interesting disease occurring during pregnancy which has many similarities to bullous pemphigoid, prompting the use of the term ''pemphigoid gestationis'' by some researchers to describe HG. Using the sera of 16 HG patients, Morrison et al. [41] found IgG antibodies which bound to a 180 kD protein in 89% of the cases. In contrasting this to BP, they also found that 71% of BP sera contained IgG antibodies which bound to a 1240 kDa band, but that 47% also bound to a 180 kDa protein which co-migrated with the HG protein. The authors conclude that this is strong evidence for immunologic cross-reactivity between HG and BP.
Adhesion Molecules. We have already considered the interrelationships of immunologic cytokines and growth factors in the activation and control of the immune response. Another area of immunology in which molecular biology has produced an explosive growth of new information is the characterization of the proteins which mediate cell/cell interactions involved in lymphocyte activation and control, and in generation of factors which mediate specific recognition. Figure 9 shows many of the components of the immunoglobulin gene superfamily [42] , a large group of peptides with strong sequence homology with immunoglobulins. The lower panel contains proteins involved in the control of T cell interaction with other cells and specific recognition: the T cell receptor (TCR) composed of alpha and beta chains plus the gamma, delta and epsilon components of CD3; CD1 (present on Langerhans cells); CD8 (present on T cytotoxic/suppressor lymphocytes); CD4 (T helper lymphocytes); and CD2 (adhesion molecule which is a receptor for LFA-3). The upper panel shows homologous molecules on other cells: FcR (the Fc-Receptor, a crucial component of recognition of antibody binding to antigen on a cellular target); PDGFR and CSF-1R (receptors for growth factors platelet derived growth factor and Colony Stimulating Factor 1); and N-CAM (a neural adhesion molecule). Cloning the genes for these proteins has been crucial in developing the tools to understand better the complex interactive biology of the immune response and inflammation. The interaction of specific recognition structures and antigens, adhesion molecules and their ligands, and growth factors or cytokines and their receptors are all crucial in the regulation of the immune response.
Another homologous member of the Immunoglobulin Super-gene family [43] is the Intercellular Adhesion Molecule 1 (ICAM-1), an adhesion molecule with important implications for cutaneous cells involved in inflammation and wound repair and differentiation. The interaction with the ligand and its receptor LFA-1 provides an important bridge between the Immunoglobulin super-family and the Integrin superfamily of cellular adhesion receptors [44, 45] . As indicated in Figure 10 , the alpha and beta chains of integrin molecules act as receptors for extracellular matrix and cell-surface ligands [44, 45] . Following a variety of exogenous stimuli (e.g., ultraviolet irradiation) and endogenous stimuli, and, to a lesser extent, even constituitively, keratinocytes produce a variety of cytokines (e.g., IL-1, contra-IL-1, IL-3, GM-CSF, IL-6, TGF-alpha and TGF-beta, Basic FGF) which influence differentiation, growth and function of many hematopoietic and non-hematopoietic cells. Reproduced with permission from Stingl et al [30] . It appears that these types of receptor-ligand binding are crucial for many interactions of leukocytes with either ECM or other cells [44] [45] [46] [47] [48] .
The three major integrin families are described in detail in Table V . The first two families mediate cell/matrix attachment. The third family, the CD11/CD18 Family, is crucial to cell/cell interactions involving all leukocytes and also the interaction of leukocytes with parenchymal cells. The interaction of the receptor LFA-1 with its ligand ICAM-1 [46] appears to be central to many cell-cell contact mediated processes, such as T and B cell activation, lymphocyte cytotoxicity, and cell migration [47] [48] [49] [50] . Families deficient in antigens ofthe CD11/18 Family exhibit a wide variety of abnormalities in immunologic and inflammatory responses [49, 50] .
During 1988, it became apparent that modulation of ICAM-1 expression may be a crucial component of control of inflammation. Although gamma interferon and IL-1 upregulate the constituitive levels of ICAM-1 on endothelial cells and fibroblasts [51] , gamma interferon and perhaps tumor necrosis factor (TNF) induce ICAM-1 expression of keratinocytes [52] . ICAM-1 expression on keratinocytes mediates LFA-1 dependent T lymphoblast attachment to the keratinocytes, as elegantly demonstrated by Dustin and collaborators [52] . This ICAM-l/LFA-1 interaction may be involved in movement of T lymphocytes into the epidermis [53] and appears to be essential for at least some forms of keratinocyte cytotoxicity [54] . The role of adhesion molecules in epidermal cytotoxicity [31] , and the induction of ICAM-1 in cutaneous disease are both areas of active investigation.
Keratins. The study of differentiation of the epidermal keratinocyte is a fundamental component of cutaneous biology. Advances in cell culture and development of techniques in molecular and cellular biology have attracted many scientists of disparate backgrounds to the study of the maturation of keratinocyte proteins such as the keratins, involucrin, filaggrin and keratolinin. The goal is to link structure and function, through study of the ultrastructure, biochemistry and molecular biology of keratinocyte differentiation. Studies of epidermal differentiation pathways will lead to better understanding of the molecular basis for the epidermal structure critical in stratum corneum organization, barrier function, and permeability to drugs, toxins and allergens. Probes for epidermal keratins are also important tools for studying epidermal differentiation and malignant transformation in both experimental and clinical settings.
Epidermal keratins comprise only two of the five types of intermediate filaments which are important cytoskeletal components. As summarized in Table VI , acidic keratins (Type I), neutral-basic keratins (Type II), vimentin, desmin, glial fibrillary acidic proteins, neurofilaments and lamins (universal components of nuclear lamina) are packaged in aggregates to form the intermediate filaments [55] . In all epithelial tissues, Type I and Type II keratins are associated with different patterns at particular stages or pathways of differentiation. The origin and differentiation of a particular cell type can be determined by identifying the type of intermediate filament in its cytoskeleton using standard monoclonal antibody probes.
The intermediate filaments are homologous in structure. As shown in Figure 11 , all types of intermediate filaments contain a highly conserved central rod domain and variable N-terminal and C-terminal segments comprising multiple domains. It is likely that these variable domains determine the variable patterns of aggregation of the different intermediate filaments. The association of Type I and Type II keratin, and multiples of this pattern comprise keratin intermediate filaments [55] . Elegant contemporary studies of the role of different domains of the cytokeratins in determining the pattern of aggregate or complex formation represent the ''state of the art'' in molecular biology [56] .
The molecular biology and molecular genetics of the cytokeratins has been a particularly fertile area of research in developmental biology. In fact, in 1987 an entire issue of Current Topics in Developmental Biology was devoted to ''The Molecular and Developmental Biology of the Keratins'' [57] . Extensive recent investigation has characterized the human keratin genes and their expression [58] , and the expression and modification of keratins during terminal differentiation of the epidermis [59] . Keratins are particularly popular with molecular biologists because 186S NORRIS, HUFF, AND WESTON they are convenient markers for differentiation in all vertebrates [60] , and different patterns of keratin expression can be used to define distinct pathways of epithelial differentiation. The developmental expression of keratins and associated molecules, such as filaggrin, are important markers of different stages of development as well as indicators of specific cell and tissue function [61] . The study of expression of keratins is an important tool in the study of carcinogenesis. Not only can keratins be used in models of malignancy as markers of neoplasms with a stratified squamous origin [62] , but also keratins can be used to study sequentially the development of malignancy and the environmental induction of malignant change [63, 64] . In 1988, regulation of keratin gene transcription was used to evaluate malignant change [65] . Aside from applications in the laboratory, probes for cytokeratins are being effectively applied by the experimental pathologist to better characterize carcinomas as to stage of differentiation [66, 67] . The keratin patterns in different epithelial structures are useful in identifying particular stages or pathways of differentiation in cell or organ culture [68] , and control of keratin expression is central to understanding how different epithelial structures develop.
The preceding section has focused on the biology of six major groups of proteins which are involved in different aspects of cutaneous structure and function. The increasing functional interactions among these groups of proteins certainly accentuate the complex and interactive aspects of biology. Study of these proteins at the molecular, cellular, organ and systemic levels has led to increasingly sophisticated understanding of normal biology and disease. In the next section, we will consider how such basic research relates practically to the diagnosis and treatment of skin disease.
THE INFLUENCE OF RESEARCH IN CUTANEOUS BIOLOGY ON THE PRACTICE OF DERMATOLOGY
This commemorative issue of the JID is filled with evidence of how basic research in cutaneous biology is related to practical understanding of disease mechanisms, and to understanding of how specific treatments are effective in different diseases. In this section we will consider in more detail how current research regarding the pathomechanisms of important skin diseases leads to better methods of diagnosis and treatment.
Major Immunologic Diseases
Bullous Disorders. In no area of clinical dermatology has modern research produced a greater impact on the accurate diagnosis and treatment of disease than in the major bullous disorders. The major forms of pemphigus, bullous pemphigoid, dermatitis herpetiformis, herpes gestationis, acquired epidermolysis bullosa, and linear IgA dermatosis can be separated based on distinctive immunohistologic findings. How these immunoreactants produce clinical blister formation has been the subject of extensive research, and the selection of anti-inflammatory and immunosuppressive treatment for these diseases has been influenced by the results of these investigations. The details of these reports are clearly presented in this volume in the review by Stingl and Krueger and in the ''Citation Classic'' by Lee.
Connective Tissue Diseases. (Lupus erythematosus)
Better understanding of the clinical subsets of lupus erythematosus and of the role of lutoantibodies and ultraviolet light in the induction of cutaneous lesions has been an important aim of research in investigative dermatology for a number of years. Direct linkage of autoantibodies to mechanisms of tissue damage in cutaneous lupus has been much more difficult than in the major bullous disorders. Granular deposits of immunoreactants at the dermalepidermal junction in SLE and DLE lesions (the lupus band test, LBT) were believed to imply a link between autoantibody and lesion development [69, 70] . However, extensive studies of the use of the LBT to predict systemic disease in SLE patients have been variably convincing [71, 72] .
Recent research in cutaneous lupus has focused on the photosensitive lupus syndromes subacute cutaneous lupus erythematosus (SCLE) and neonatal lupus erythematosus (NLE). The strong association of these syndromes with antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La [73, 74] has led to a series of investigations attempting to link these autoantibodies to the tissue damage seen in photosensitive lupus lesions. Binding of anti-SS-A/Ro antibodies to human keratinocytes has been shown to occur both in vitro and in vivo [75, 76] , and is augmented by UVL and estradiol [75, 77] , two trigger factors of lupus. The isotype profile of anti-SS-A/Ro antibodies in the sera of SCLE patients [78] and in the tissue of SCLE lesions is similar, and can be reproduced in model systems by injection of anti-SS-A/Ro into nude mice engrafted with human skin [76, 79] . There is growing evidence that these antibodies [55] .
are involved in producing tissue damage. Also, current investigations into the immunogenetics of anti-SS-A/Ro antibody production [80] are directed at determining the alleles which determine antibody production and/or disease.
Treatment of cutaneous lupus erythematosus has benefited from the development of effective topical steroids, the use of antimetabolites and anti-inflammatory drugs in SLE, the use of antimalarials, the development of broad-spectrum sunscreens, and more recently the development of retinoids [81] .
Scleroderma. In spite of extensive and productive study of the complex cellular interactions involved in the production of fibrosis of multiple organs in scleroderma, no effective treatment has been developed. Many factors are involved in the genesis of scleroderma. Immunologic reactivity seems to be central in natural scleroderma and in graftversus-host disease animal models of scleroderma [82] . Growth-factor stimulation of fibroblast synthesis of collagen is central to the production of fibrosis [83] [84] [85] . As previously discussed in this issue, growth factor synthesis is associated in scleroderma tissue with perivascular infiltrates [14] . Mast cell degranulation also appears to be involved in some scleroderma models [86] . Detailed understanding of the factors which control immunologic and growth factor-dependent fibrosis [87] are most likely to lead to clinically relevant treatments.
Dermatitis
Contact Hypersensitivity. Investigative dermatologists and immunologists have focused on understanding the mechanisms of contact hypersensitivity and allergic contact dermatitis for many years, producing an impressive record of accomplishment. We understand in great detail complex cellular interactions involved in contact hypersensitivity, now even at the molecular level. These events are described in detail in the review by Stingl and Krueger, in the ''Citation Classic'' by Soter, and in previous sections of this chapter on immunologic cytokines and adhesion molecules.
Detailed study of the antigens or sensitizers which induce allergic contact dermatitis has also been a major focus of research in basic research laboratories, in clinical departments and in the laboratories of the pharmaceutical industry. The fact that the most cited paper from the JID concerns the Maximization Test [88] to identify contact sensitizers underlines the activity of research to understand the mechanisms of sensitization and to identify real or potential sensitizers. In clinical practice this has been translated into accurate patch testing and effective identification and elimination of sensitizers. The development of potent topical and oral steroids has made treatment quite satisfactory.
Photoimmunology has developed as an outgrowth of research in mechanisms of contact hypersensitivity. Ultraviolet radiation is an important immunomodulator affecting many aspects of cutaneous immunology and inflammation [89] . This detailed understanding of mechanisms of immunosuppression helps us to understand the impressive effects of UVL in treating many skin diseases.
Photoallergy is based on many of the same mechanisms as contact hypersensitivity. The detailed study of mechanisms of photoallergy and phototoxicity has important clinical application in evaluating lightinduced drug reactions and photo-related reactions to topical chemicals. The epidemic of persistent light reactions was controlled by identifying the photosensitizers involved, and by carefully screening future compounds as photosensitizers.
Atopic Dermatitis. Not all cutaneous conditions have yielded to the tools of modern investigation. One of the most common skin conditions, atopic dermatitis, continues to frustrate current investigators, just as it did their predecessors. Yet small pieces of the atopic dermatitis puzzle tantalize us with the promise of a major scientific breakthrough.
Studies of the pathology of atopic dermatitis began in the Journal and continue to serve as the basis for current investigation [90, 91] . The observed prominence of the cutaneous mast cell and the Langerhans cells in these studies provides the impetus for involvement of the immune system in atopic dermatitis [91, 92] . The observation of elevated skin histamine levels was first reported in the Journal [93] .
The contradictory findings of an inflammatory disease which has evidence of cellular immunodeficiency, altered pharmacologic reactions, paradoxical vascular responses, abnormal sensory nerve responses, and a defective epidermal barrier have been difficult to encompass with a unifying concept. Jon Hanifin, Kevin Cooper and their colleagues have focused on second messenger cellular systems in hopes of detecting a common defect in the recognition of cellular modulatory signals, and their concept of altered signal transduction by a receptor-mediated cAMP second messenger has been partially substantiated by recent investigations [94] . The cellular immunodeficiency of atopic dermatitis has also been well documented by a large number of careful investigations [95] . The complexity of atopic dermatitis has been appreciated as more abnormal responses and interactions are catalogued [96] .
Despite large gaps in our understanding of atopic dermatitis, scientific advances in pharmacology have greatly improved our therapy. We now employ elegant topical glucocorticosteroid preparations which provide prompt relief, instead of messy tars which stink and stain; we now utilize specific anti-staphylococcal antibiotics, whereas previously atopic dermatitis patients suffered daily from chronic cutaneous infection; we can provide antihistamines and other antipruritics to relieve the intractable itching, and we have a selection of phototherapy protocols to offer.
The Journal has published a large number of studies on atopic dermatitis in the past half century, and many others have appeared in other prominent journals with the frustration that, although a large volume of data have been accumulated regarding atopic dermatitis, we are currently not very close to understanding the disease. It may be the fact of cutaneous biology that atopic dermatitis is a disease for the twenty-first century to master.
Psoriasis. Investigative studies of psoriasis continue to produce evidence of abnormalitis in epidermal proliferation, epidermal differentiation, and inflammation in psoriatic skin, but it is rarely clear whether the defects demonstrated are the cause, or the result, of the disease. Perhaps, the host-specific abnormality that leads to psoriasis is not a single defect; there may be a number of abnormalities which singly, or in combination, lead to.psoriasis. In addition, there also may be a number of environmental stimuli which are critical determinants in the genesis of psoriasis.
Recent studies of psoriasis have documented further the abnormal proliferation and differentiation characteristic of psoriatic epidermis [97] [98] [99] . Other findings that may be related to these abnormalities include defects in signal transduction in cell membranes [100] [101] [102] , increased polyamine synthesis and ornithine decarboxylase activity [103, 104] , and increased binding of epidermal growth factor [105] . Products derived from proteases and from enzymes that metabolize eicosanoids may also lead to proliferative and differentiation abnormalities, as well as to the influx of inflammatory cells [106] [107] [108] . Powerful chemattractants, such as leukotriene B4, appear to be important factors in the neutrophilic inflammation characteristic of psoriasis [108] . Further investigations have shown endothelial cell abnormalities and increased adhesion of lymphocytes to psoriatic endothelium [109, 110] .
Considerable attention has been focused recently on a hypothesis that the immune system and interactions of cells of the immune system with cells of the skin leads to psoriasis (see Figure 12 ) [110] . The presence in active psoriatic lesions of increased numbers of epidermal T-lymphocytes, of HLA-DR positive cells, and of Langerhans cells are observations that support this hypothesis [111, 112] . Active psoriatic lesions have been observed to have a larger proportion of helper T lymphocytes, while resolving lesions contain more suppressor T lymphocytes.
Investigative efforts have provided a number of novel therapies for psoriasis. Therapy of psoriasis with PUVA and with retinoids (see the ''citation classic'' by Bernhard and the review by Saurat) may affect both 188S NORRIS, HUFF, AND WESTON of the proliferative-differentiation abnormalities and the inflammatory processes. A recent fascinating therapeutic observation is that the immunosuppressive drug cyclosporin A may be of benefit in psoriasis [113] . This unique drug may work through its effects on the immune system, or it may have a direct effect upon keratinocyte proliferation [114, 115] . Attention to how this drug and other therapies work in psoriasis may provide valuable clues to the pathogenesis of this important dermatologic disease.
Lichenoid Dermatitis. Lichen planus and histologically similar lichenoid eruptions are an interesting and important form of papulosquamous dermatitis which has been extensively studied by histologic and immunohistologic techniques. Still, little is known about the immunologic mechanisms of these cutaneous reaction patterns. A series of papers has provided new insights into possible mechanisms for the dense dermal infiltrate and keratinocyte damage seen in lichenoid dermatitis [116, 117] . In a mouse model of lichenoid tissue reactions produced by injection of autoreactive T-cell clones, Shiohara and his colleagues have found that different clones produce distinct patterns of tissue reactivity. Some clones produce a dense mononuclear infiltrate and keratinocyte hydropic change as in lichen planus [Fig 13] . This model is being used to study the factors involved in epidermotropism [117] of lymphocytes and keratinocyte cytotoxicity and may produce practical therapeutic approaches to epidermotropic dermatitis and malignancy.
Fibrotic Skin Diseases
The factors involved in immunologic fibrosis have already been discussed in relation to scleroderma. The review by Uitto, Olsen and Fazio clearly describes the great progress made in the study of primary diseases of altered collagen and elastin synthesis and deposition, plus understanding of changes which occur with aging and UV radiation. Of central importance in modern research of these diseases is understanding that the altered regulation of collagen synthesis can occur at the pretranslational level [118] . This is reflected in two current JID papers. Olsen et al. illustrate that elevated ECM synthesis in lipoid proteinosis may be caused by elevated mRNA for procollagen [119] in patients' dermal fibroblasts grown in vitro. Sephel et al. show that increased elastin production by progeria skin fibroblasts is controlled by elevated steady-state levels of elastin mRNA [120] . Better understanding of the molecular basis for altered synthesis of connective tissue components may lead to better clues to practical ways to regulate the process and produce normal connective tissue in patients with this group of diseases.
Acne Vulgaris
One of the true ''success stories'' of investigative dermatology is the study of the pathogenesis and treatment of acne vulgaris. The pathogenesis of this complex cutaneous inflammatory disease has been well characterized, and effective treatments reversing the major components of the pathomechanism have been developed. In 1988, the use of combination therapy and the effective use of modern retinoids have made it possible to control even the most severe recalcitrant cystic acne.
The decade of the 1970s was a golden age in acne research, during which time the major components of the pathogenesis of this disease were identified. The JID was a major source for landmark papers of that era, and the state of understanding of research in sebaceous gland physiology and its relationship to acne at that time was well presented in a review by Kligman [121] . The development of acne is based on five major components: follicular hyperkeratosis; enhanced sebaceous activity; overgrowth of Proprionobacterium acnes (historically, Corynebacterium acnes); generation of chemotactic substances; and recruitment of a neutrophilic infiltrate which produces tissue damage and scarring. Follicular retention hyperkeratosis is a uniform characteristic of sebaceous follicles in acne patients, and appears to be the necessary factory for the development of the co-medone, the primary lesion of acne [122, 123] . The composition of sebum in acne patients appears to be able to induce acne lesions in animal models [124] and to influence acne by directly stimulating follicular hyperkeratosis [125] and promoting growth of P. acnes. The bacterium P. acnes appears to be necessary for the development of the retention hyperkeratosis which produces comedonal lesions, and also for the production of inflammatory lesions [126] [127] [128] . Inflammation is produced by direct effects of products of P. acnes on the follicular epithelium [129] , by production of irritating free-fatty acids from sebum [130, 131] , and by the generation of chemotaxins [132] . The neutrophilic infiltrate which ensues produces local erythema and often severe scarring and sometimes epidermal atrophy.
Hormonal influences in the development of acne have been well documentated [133] [134] [135] [136] . Not only do systemic androgen levels influence sebaceous gland activities and acne development [133] [134] [135] , but cutaneous androgen metabolism may also be a critical part of the genesis of acne lesions [136] . The importance of this work in investigative dermatology can be judged by the fact that four of these papers are in the top 200 most-cited papers in the JID [133, 134, 136, 137] .
The use of oral and topical antibiotics, benzoyl peroxide and topical retinoic acid reverses these pathogenic changes in acne patients and controls most patients. For recalcitrant patients or those with particularly severe acne, the introduction of 13-cis-retinoic acid was an important development [138] . This drug reverses retention hyperkeratosis, decreases sebum production, inhibits P. acnes growth, and strongly inhibits the inflammatory reaction in the skin [139] .
Contemporary research in acne and sebaceous gland function is utilizing modern methods of cell culture and accurate probes for differentiation proteins to grow sebaceous follicular cells in culture and study their differentiation patterns in acne lesions [140] and in cell cultures exposed to the inciting agents of acne.
Photobiology
The review by Bickers earlier in this volume succinctly presents the impact of some of the major discoveries in photobiology over the past 50 years as reported in the Journal of Investigative Dermatology. The mechanisms of ultraviolet light as an agent of photoallergy and phototoxicity, as the cause of photoaging, in photocarcinogenesis, and in induction of photosensitive disease have been productively studied. This knowledge has been applied to ways to avoid ultraviolet light induced disease: to screening to remove photosensitizers from topical medications and toiletries, and to the development of potent sunscreens, in itself a major development in medicine. In addition, the therapeutic effects of ultraviolet radiation are now much better understood through studies in photoimmunology.
Certainly one of the most dramatic effects of photobiology in the practice of dermatology has been the development of PUVA and its application to the treatment of many skin diseases. This story is presented with sparkling clarity by Jeffrey Bernhard in his ''Citation Classic'' commentary.
There is incredible public interest in the mechanisms of photoaging and in ways to reverse the changes. Two contemporary studies from the University of Pennsylvania investigate the degradation of elastin fibers by UVL [141] and the ultrastructural features of chronic heliodermatitis. [142] Chronic sun-damaged skin contains a lymphohistiocitic infiltrate with prominent mast cells in association with fibroblasts. Perhaps the concepts discussed earlier with respect to scleroderma also apply to chronic sun-damaged skin.
Pigmentary Disorders
The review by Nordlund et al. on the historical development of melanocyte biology indicates the importance of the melanocyte in cutaneous biology and the importance of disorders of pigmentation and melanoma in medicine. The development of techniques for the culture of melanocytes has greatly advanced attempts to understand the cell biology of melanocytes and the control of melanization. There is especially great interest in identifying the biologically relevant factors which influence melanocyte proliferation and migration and melanization in vivo. An example is the current efforts to determine whether vitamin D and its metabolites directly influence melanization. Mason et al. [143] tested the effects of vitamin D and its metabolites on melanocyte cell lines, and found that all cell lines bound 1,25(OH) 2 D3; and evidenced increased tyrosinase activity in response to active vitamin D. Calcitonin effects on these cell lines was variable. Tomita et al. [144] found that cholecalciferol (Vitamin D 3 ) enhanced immunoreactive tyrosinase activity in cultured human melanocytes, speculating that the photoactivation of vitamin D3 from provitamin D3 may be a direct mediator of UVL-induced melanization. However, Mansur et al. did not find that active vitamin D3 (or its precursors, or its metabolites) stimulated melanogenesis in cultured human melanocytes [145] , raising questions about the true role of vitamin D in pigmentation.
Culture of human melanocytes has also facilitated the study of pigmentary disorders associated with inflammatory reactions. Vitiligo is a complex process which is found in man and many animal models, and there is considerable indirect evidence that one of the basic mechanism is autoimmune destruction of melanocytes. A functional role for antimelanocytes antibodies in vitiligo was verified by two different antibody dependent immunologic mechanisms [146] , which employed normal melanocytes in culture as sensitive targets of immunologic cytotoxicity. In addition, melanocytes in culture showed greater susceptibility than cultured keratinocytes, fibroblasts and endothelial cells to lysis by hydrogen peroxide, a mediator produced in many types of inflammatory reactions [147] . This susceptibility to toxic oxygen products may be interpreted as a possible mechanism for the melanocyte dysfunction evident in post-inflammatory hypopigmentation. Advances in cell culture techniques have made possible the detailed study of melanocyte function in normal and pathologic circumstances.
Much interest in clinical studies has centered on ways to encourage repigmentation of depigmented lesions of vitiligo. Application of modern knowledge of cell movement, matrix proteins and growth factors may provide the key to stimulation melanocyte repopulation of depigmented skin.
Wound Care Wound Healing. Practical approaches to care of nonhealing wounds is an important result of the extensive studies on wound healing.
Modern semipermeable dressings and modern disinfectants and antibacterial ointments have been developed based on basic research on the factors influencing wound healing. A whole new chapter on promotion of wound healing is opening, with clinical trials using recombinant growth factors on non-healing ulcers in humans.
Artificial Skin (Skin Equivalents). An emerging practical application derived from basic research in immunology and cell biology is the use of allogeneic dermis, or an artificially constituted dermal equivalent, and cultured autologous keratinocytes to produce a ''skin equivalent'' suitable for grafting onto burns, surgical defects, or ulcers of the skin. The epidermis, with its Langerhans cells, appears to be the most immunogenic component of skin allografts, but recently available keratinocyte culture techniques have provided a convenient means by which epidermal cells of a potential graft recipient can be harvested and expanded in numbers and then used to produce an epidermal autograft [148] [149] [150] . Regardless of which technique is used to produce a dermis, the connective tissue is eventually colonized by cells of recipient origin [151] [152] [153] [154] . By providing cultured autologous keratinocytes to cover the underlying fibrovascular stroma, these techniques allow more rapid coverage of large defects than would occur as a result of migration of cells from the wound edges. The stratified epithelium that is eventually produced at the graft sites with these methods appears to be relatively normal in both its structure and function, although the appearance may not be optimal [149] [150] [151] [152] [153] , As these practical applications of recent investigative dermatology improve, perhaps we will have effective, life-saving methods of covering burns and other cutaneous defects with the equivalent of skin autografts.
Prenatal Diagnosis
Prenatal diagnosis of skin diseases became a reality in the 1980s, as a direct result of scientific technology developed in the preceding decade. Over 150 distinct genetic skin diseases have been detected in man, many 190S NORRIS, HUFF, AND WESTON of which result in chronic suffering for the affected individuals. Thus, the interest in prenatal diagnosis of skin diseases has been keen. For the families with a history of a devastating genetic skin disease, there was no prenatal diagnosis prior to this decade.
Modern obstetrics and perinatal medicine first developed ultrasonography, which was useful in the prenatal diagnosis of major malformations, then mid-trimester amniocentesis for biochemical measurements of amniotic fluid. Skin diseases were not amenable to such strategies, and it requied the development of fetoscopy and fetal skin biopsy to enable one to diagnose skin diseases prenatally.
The pioneering work of Karen Holbrook and George Odland in 1980 opened the door for the prenatal diagnosis of skin diseases by carefully documenting the normal ultrastructure and morphology of the firsttrimester embryo and the second-trimester fetus [155] . Shortly after, Sherman Elias and Nancy Esterly reported the prenatal diagnosis of harlequin ichthyosis [156] . Prenatal diagnosis of the genetic mechanobullous diseases followed. Robin Eady and colleagues described the prenatal diagnosis of junctional epidermolysis bullosa, and Ingrid AntonLamprecht, of recessive dystrophic epidermolysis bullosa [157, 158] . Oculocutaneous albinism was the next to be diagnosed prenatally with a report from Robin Eady in the Journal [159] .
In addition to ultrastructural analysis of fetal skin samples, prenatal diagnosis of skin disease has also been successful after biochemical analysis of skin cells cultured from fetal skin biopsies. Eugene Bauer and his colleagues were able to diagnose recessive dystrophic epidermolysis bullosa with biochemical studies of collagenase from cultured fetal fibroblasts [160] .
Since ultrastructural analysis was not widely available, Heagarty and Eady applied immunofluorescent techniques to fetal skin samples for the rapid prenatal diagnosis of epidermolysis bullosa [161] . This advance was made possible by the development of monoclonal antibodies to the structural components of the dermal-epidermal junction, and the first description of this technique by Hintner and colleagues in 1981, which allowed diagnosis of the major types of epidermolysis bullosa [162] .
Despite the reports of prenatal diagnoses in the ichthyoses and mechanobullous diseases, limitations of the current technologies have recently been detailed [163] ; and the majority of genetic skin diseases cannot be diagnosed in the prenatal period. Somehow, the feeling prevails that the best is yet to come for prenatal diagnosis of skin diseases. With the powerful sensitivity and specificity of molecular biology techniques, detection of abnormal genes encoding for genetic skin disorders holds great promise for prenatal diagnosis in the decade ahead.
Dermatopathology
The contributions of basic research have revolutionized the practice of skin pathology in the past 15 years. Immunofluorescence microscopy has enabled the skin pathologist to distinguish the major bullous diseases (see review by Stingl and Krueger). Immunophenotyping of cutaneous infiltrates began as an investigative tool in the 1970s, as demonstrated by two early landmark papers by Edelson and Thivolet [164, 165] , and has grown in application to become a broadly used tool in clinical and pathologic research and a clinical diagnostic tool. The development of monoclonal antibodies and superior labeling and fixation techniques has greatly expanded the diagnostic repertoire of the skin pathologist [166] . Immunoperoxidase or immunogold labeling of the surface of cells infiltrating the skin enable the pathologist to distinguish malignant from benign lymphohistiocytic infiltrates [167] . This has been particularly helpful in the diagnosis of cutaneous T cell lymphoma by detection of the CD4 reactive epidermal lymphocytes [168] , and in distinguishing benign from malignant histiocytosis [169] .
In some circumstances the early promise of such immunodiagnostic techniques has not resulted in improved diagnosis in skin pathology. This has been particularly true of the innumerable immunophenotyping studies of benign inflammatory skin diseases [167] . It is now apparent that the wide variety of inflammatory skin diseases demonstrate quite restricted patterns of infiltrating leukocytes, mimicking patterns seen in other tissues.
Immunoperoxidase techniques have been invaluable to the skin pathologist in distinguishing some forms of cutaneous malignancies. For example, the spindle tumors demonstrate such overlapping morphology that they are often impossible to distinguish by routine histopathology. The modern skin pathologist with a panel of highly specific or even monoclonal immunologic reagents is now able to make a specific diagnosis. Atypical fibroxanthomas, for example, react with antibodies to vimentin, alpha-1 antitrypsin, and alpha-1 antichymotrypsin, while squamous cell carcinomas react with panels of antikeratin antibodies; malignant melanoma reacts with S-100 and monoclonal antimelanoma antibodies; and leiomyosarcomas react with anti-desmin antibodies [170] .
The experimental pathologist has applied such immunoreagents to discover the spirochete which is the causative agent of Lyme disease [171] , to detect human papillomaviruses in a variety of epithelial growths [172] , and to find herpes simplex virus antigens in skin lesions of erythema multiforme [173] .
The dermatopathologist of the next decade must adapt to the ever improving panels of diagnostic reagents, including not just monoclonal antibody probes, but also molecular and nucleotide probes which will become the diagnostic reagents that will further sophisticate and refine the field of skin pathology.
Carcinogenesis
The review in this issue by Bickers and Lowy provides an excellent perspective on the development of the major theories of carcinogenesis, and a sampling of important papers in the development of modern models of carcinogenesis. The JID continues as an important forum for publication of papers in ultraviolet and chemical carcinogenesis, and for papers concerning viral carcinogenesis.
A high priority in investigative dermatology is the development of probes for human papillomaviruses to diagnose particular papilloma presentations that are associated with subsequent development of cancer [174] . The role of interferons and other biologic response modifiers in the treatment of papilloma virus-associated skin lesions is also an important area of research [175] .
One increasingly important area of research in viral oncogenesis is the area of retrovirus infection. Not only is the skin commonly involved with a variety of infections and Kaposi's sarcoma in AIDS patients, but the human immunodeficiency virus is found in epidermal Langerhans cells [176] . A recent clinically oriented symposium of the ESDR focused on the problem of AIDS, considering the biology of the disease, and new clinical approaches [177] . The editors hope to have the opportunity to review more work on the cutaneous role in this important syndrome.
Percutaneous Absorption
The structural, biophysical and biochemical factors which influence percutaneous absorption, transepidermal water loss, and the epidermal barrier are all reported in the JID, and are recognized by the Editorial Board as one very important area in which basic research produces practical benefits. The differentiation of epidermis and development of an intact stratum corneum are considered in detail in the review by Holbrook in this issue. Basic research in the role of intermediate filaments, filaggrin, keratolinin and other proteins in formation of the stratum corneum are a major basic scientific influence in investigative dermatology. Detailed morphologic, biochemical and biophysical study of the role of stratum corneum lipid and proteins in formation of the epidermal barrier has produced an increasingly sophisticated knowledge of the structure/function relationships in the stratum corneum, as exemplified by several current JID papers [178] [179] [180] . This is an area of research where basic science and practical application merge, and the development of future transepidermal and transdermal delivery systems is surely based on today's research of the epidermal barrier.
New Approaches to Treatment
The scientific basis for new approaches in treatment of skin disease frequently appear in the Journal of Investigative Dermatology. The review by Saurat on Clinical Research certainly illustrates this, and several examples from 1988 confirm this point. One area of great professional and lay interest is the use of retinoids to reverse the effects of photoaging in the skin. A recent paper by Bryce in the Journal [181] illustrates some of the relevant biological effects of topical retinoids in a hairless mouse model of photoaging. These investigators demonstrated that topical tretinoin and isotretinoin both reversed several characteristic findings in photoaging skin in the mouse, and produced objective quantitative evidence of repair. As illustrated in Figure 14 , significant dermal repair was induced in irradiated skin by topical retinoids. Such careful animal investigation provides the basis for experimental and therapeutic protocols in humans to study further the role of retinoids in the reversal of adverse effects of UVL.
There is also considerable clinical and investigative interest in the control of hair growth and in the reversal of male pattern hair loss, sparked by the authorization by the FDA for the use of topical minoxidil for male pattern hair loss. Buhl and his colleagues [182] have examined the growth characteristics of isolated hair follicles in organ culture and the effects of minoxidil. Interestingly, they found that minoxidil added to cultures stimulated follicular DNA and protein synthesis and incorporation of protein into hair matrix. Direct stimulation of follicular function appears to be one of the potential mechanisms of action of minoxidil in restoring hair growth.
Organ culture of isolated sebaceous glands was used by Sawaya et al.
[183] to study selected aspects of the metabolism of steroid hormones in the skin. They found that even weak androgens could be metabolized to more active androgens in sebaceous glands, and that such glands from the scalp of bald men had increased activity. Thus, not only is the skin an important site of generation of active androgens, but this activity is greater in the scalp of balding men than in controls.
Photobiology has produced a number of important therapeutic advances in recent years. The logical extension of the PUVA story is the recent publication in the Journal of two contributions from the members of the Photochemotherapy Follow-up Study [184, 185] , documenting the actual five-to-ten-year risks of skin cancer and cardiovascular disease, and cancer and cause of death in PUVA patients. PUVA has also been shown to be an effective repigmenting treatment in vitiligo, and other photoactive drugs, such as Khellin, have great promise as improved repigmenting agents. As basis for clinical use, a recent paper in the Journal documented the photo-therapeutic, photobiologic and photosensitizing properties of khellin [186] .
A direct result of the extensive research on PUVA and especially on the immunosuppressive effects of PUVA is the development of extracorporeal photochemotherapy for the treatment of cutaneous T cell lymphomas (CTCL). This unique form of therapy involves separation of leukocytes from patients in a special pheresis machine, extracorporeal irradiation of psoralen-contaimng cells 'with UVA, and reinfusion of the irradiated cells back into the patient. Impressive success with recalcitrant CTCL patients has been reported [187] , and it is likely that this therapy will be effective in other patients with diseases such as scleroderma and rheumatoid arthritis, and in organ transplant patients [188] .
The use of lasers in medicine is an excellent example of the application of modern technology to practical clinical problems. Certainly one of the most impressive examples of this is the treatment of port-wine stains with the pulsed dye laser, which has been recently shown to produce excellent clinical responses in children, as well as adults [189] . The use of this laser is based on the selective absorption of the emitted light by hemoglobin in hemangiomas and the minimal heat dispersal due to the pulse length and spot size. A recent paper by Tan et al. [190] in the Journal documents some of the histologic findings in resolution of port-wine stains following laser treatment. A prominent role of mast cells in the neovascularization can be inferred from the results (Fig 15) . A number of other papers on the biological effects of lasers [191, 192] demonstrate the commitment of the 
CONCLUSION
As the finale to this special issue commemorating the founding of the Society for Investigative Dermatology, Inc., and the Journal of Investigative Dermatology, we have provided our own perspective on the state of research in investigative dermatology in the 50th Anniversary year, and have given examples of the impressive impact of basic research on the practice of dermatology. If it is true that ''the best of prophets of the future is the past'',* then what does the future hold for investigative dermatology? Our prediction is for continued strong and productive collaborations between basic and clinical investigators to discover the unknowns in cutaneous biology, a continuation of the pattern that has produced an impressive record of accomplishment over the past 50 years. We also predict that new and innovative treatments for skin disease will be developed based on basic and clinical research, and will often utilize the accessibility of the skin to irradiation and lasers, to ultrasound and other physical modalities, and to the topical applications of new drugs and biological response modifiers.
The techniques applied to cutaneous biology have become progressively more elegant, and increasing numbers of scientists from academic departments other than dermatology have found the skin to be a fertile area of research. We must continue and even expand this application of basic research to understanding and treating clinical disease. To accomplish this and to assure that investigative dermatology survives as a cohesive and comprehensive area of investigation, we must guarantee that both the basic scientist and the clinical investigator feel represented in the Journal and its sponsoring societies, the SID and ESDR. We are committed to expanding the involvement of Ph.D. investigators in all aspects of the Journal organization: as reviewers, as authors, and as members of the Editorial Board. In this 50th Anniversary year, we propose to expand the Editorial Board of the Journal to increase the involvement of Ph.D. scientists, especially in the areas of molecular and cellular biology.
The Founders of the SID and JID were committed to the concept of a unified and inclusive approach to the study of cutaneous biology, encompassing all aspects of modern science. To perpetuate this vision, we must recruit actively the best scientists to study the biology of the skin and to apply this knowledge to clinical dermatology. It is essential for the continued success of the Journal of Investigative Dermatology that both the basic and clinical investigator be involved in all aspects of the Journal and its sponsoring societies, and that the newest technology be applied intelligently to basic and clinical investigative problems. Such steps are necessary for the Journal to continue to be considered as the best single forum for the presentation of the entire spectrum of cutaneous biology.
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